Theriva BiologicsTOVX
13F holders, Q4 2024 (December 31)10holders −8
1new positions
9sold out
$1.75avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings, down 8 from Q3 2024. 1 opened new positions and 9 sold out. The largest holders were UBS Group AG ($29K), Citigroup Inc. ($14K) and BlackRock, Inc. ($13K).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 9 | $641K |
All 13F filers, Q3 2024 → Q4 2024: 8,497 shares bought and 465,952 shares sold, net −457,455 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| UBS Group AG | 0.00% | Reduce -8.1% | 16,406 | $29K |
| Citigroup Inc. | 0.00% | New | 7,756 | $14K |
| BlackRock, Inc. | 0.00% | No change | 7,568 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +110.4% | 1,391 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,294 | $2K |
| Bank of America Corp. | 0.00% | Add +122.2% | 20 | $35 |
| Iron Horse Wealth Management, LLC | 0.00% | No change | 14 | $25 |
| IFP Advisors, Inc | 0.00% | No change | 11 | $19 |
| SBI Securities Co., Ltd. | 0.00% | — | 10 | $18 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.